In re FibroGen, Inc. Securities Litigation
FibroGen, Inc.
FibroGen investors sued the company alleging securities fraud. A settlement was reached for shareholders who bought FibroGen stock or options during the class period. The claim filing period has closed.
Who may qualify
You qualify if you purchased or acquired FibroGen, Inc. securities (including options) between December 20, 2018 and July 15, 2021, and are not a company insider or defendant.
How to claim
This claim is publicly available and free to file yourself directly with the settlement administrator. Read the official eligibility rules and deadline before filing - they are the source of truth. PendingMoney can find, fill, and track it for you, but you can always do it on your own.
View official requirements on fibrogensecuritieslitigation.comNot sure if this one - or others - may be waiting in your name? Run a free 2-minute check.
Find My Pending MoneyEligibility and payouts are not guaranteed and are decided by the settlement administrator, not PendingMoney. PendingMoney is not a law firm and does not provide legal advice. Available to U.S. residents only.